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Four Cochrane respiratory reviews of relevance to physiotherapeutic practice are
discussed in this overview. Physiotherapists aim to improve ventilation for people with
respiratory disease, and approach this using a variety of techniques. As such, the reviews
chosen for discussion consider a wide range of interventions commonly used by
physiotherapists: breathing exercises, bronchopulmonary hygiene techniques and physical
training for peripheral and respiratory muscles. The reviews show that breathing exercises
may have beneficial effects on health-related quality of life in asthma, and that inspiratory
muscle training (IMT) may improve inspiratory muscle strength. However, the clinical
relevance of increased respiratory muscle strength per se is unknown, and the longer-term
effects of breathing exercises on morbidity have not been considered. One review clearly
shows that bronchopulmonary hygiene techniques in chronic obstructive pulmonary
disease (COPD) and bronchiectasis increase sputum production. Frequent exacerbation is
associated with increased sputum and high bacterial load, suggesting that there may be
important therapeutic benefit of improved sputum clearance. Future studies evaluating
the long-term effects of bronchopulmonary hygiene techniques on morbidity are
recommended. In the third review, the importance of pulmonary rehabilitation in
the management of COPD is once again reinforced. Physiotherapists are crucial to the
delivery of exercise training programmes, and it is likely that the effects of pulmonary
rehabilitation extend to other important outcomes, such as hospital admission andElsevier Ltd. All rights reserved.
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overview highlights important practice points of relevance to physiotherapy, and
recommendations for future studies.
& 2007 Elsevier Ltd. All rights reserved.Contents
Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2430
Systematic review 1: breathing exercises in asthma. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2431
Effects on lung function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2431
Medication usage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2431
Exacerbations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2431
Health-related quality of life . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2431
Implications for physiotherapists . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2431
Practice point . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2431
Systematic review 2: bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary
disease and bronchiectasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2431
Pulmonary clearance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2431
Pulmonary function and oxygenation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2432
Methodological limitations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2432
Implications for physiotherapists . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2432
Practice point . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2432
Research priorities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2432
Systematic review 3: pulmonary rehabilitation for chronic obstructive pulmonary disease. . . . . . . . . . . . . . . 2432
Health-related quality of life . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2432
Maximal exercise tolerance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2432
Functional exercise tolerance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2433
Methodological limitations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2433
Implications for physiotherapists . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2433
Practice point . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2433
Research priorities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2433
Systematic review 4: inspiratory muscle training for asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2434
Effects of training on maximal inspiratory pressure (cm H2O) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2434
Effects of training on lung function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2434
Effect of peak expiratory flow rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2434
Methodological limitations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2434
Implications for physiotherapists . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2434
Practice point . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2434
Research priorities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2434
Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2434
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2435Introduction
Physiotherapists are recognized as playing an important role
in the management of patients with respiratory disease.
They use a variety of strategies aimed at reducing the work
of breathing, improving ventilation, increasing function and
enabling relief of dyspnoea. Chest physical therapy may
include positioning to maximize ventilation, management of
secretion retention, breathing and whole-body exercises to
improve strength and function, and the application of
adjuncts designed to maximize lung function. Chest physical
therapy is not a new concept; indeed over a century ago
deep breathing exercises were promoted in order to
‘strengthen the chest, lungs and stomach’,1 and positioning
and exercise were proposed as beneficial therapies for the
perception of dyspnoea.2
However, research concerning the effect of physiother-
apeutic interventions is often methodologically weak andinsufficiently robust to make clinical recommendations.3–5
Many studies are small, of short duration and do not
adequately define their target population. Furthermore,
few studies in physiotherapy use sham treatments. To
confuse matters further, there is discussion within the
profession as to what constitutes ‘conventional chest
physical therapy’, with commentators advocating a varied
approach depending upon the underlying pathological
problem.6 Thus, the formal randomized-controlled trial
(RCT) is often considered inappropriate for evaluating
physical therapy. Unlike many medical treatments, blinding
of participant to treatment group may not be possible, and
standardization of technique can be difficult to achieve.
Pharmaceutical and commercial sponsorship of clinical trials
in much of the world has contributed to the understanding
of chronic respiratory disease and its response to pharma-
ceutical and surgical intervention.7–9 Physiotherapeutic
interventions, while rarely assessed in such sample sizes,
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part of ‘usual care’. This may reflect both the extent to
which it has come to be accepted as routine management,
and the necessity to establish optimum care.10 Advances in
outcome measurement and the increasing recognition of the
value of health-related quality of life treatment of
respiratory disease11 may prove to be more sensitive to
physiotherapeutic interventions than measures such as lung
function and mortality.
However, a rehabilitative, multidisciplinary intervention
is as deserving of formal assessment as any other, and the
methodological rigour demanded by organizations such as
the Cochrane Collaboration will help to preserve the unique
identity of the physiotherapy evidence base. The purpose of
this overview then is to consider the evidence from previous
robust review documents, predominantly those of the
Cochrane Respiratory Review Groups, and to try and
illuminate some of the areas that physiotherapists are
involved with in the management of respiratory disease.
Systematic review 1: breathing exercises
in asthma
Breathing exercises in the management of asthma have been
formally evaluated and considered in this systematic re-
view.12 Seven RCTs were included, in which breathing
retraining, lower abdominal breathing, Buteyko technique
or yoga that included breathing exercises, were compared
with asthma education or waiting list controls.
Effects on lung function
Pooled data from two of the studies13,14 showed a non-
significant decrease in reduced forced expiratory volume in
1 s (FEV1) in the treatment group compared with control.
However, FEV1 was significantly higher after the treatment
period in one small study (n ¼ 17) that compared yoga
breathing techniques with control.13 In one study, peak
expiratory flow rate significantly improved as a result of
breathing exercises,15 although in another there was no
difference in evening or morning values.14
Medication usage
Medication usage was recorded in two trials.16,17 In both,
rescue bronchodilator use was reduced in the treatment arm
compared with control groups. Of note, beta-2 agonist usage
also decreased in the study by Bowler et al.17 which
evaluated the Buteyko Breathing Technique; however,
stratification of participants according to high or low usage
and recruitment on the basis of high use of rescue
medication limit this finding.
Exacerbations
Effects of breathing re-training on exacerbations of asthma
were evaluated in two studies with contradictory results.
One study showed a positive effect with a reduction of 1.27
attacks per week,15 whereas no difference was seen
between groups in the other.13Health-related quality of life
Health-related, quality-of-life measures, although differ-
ent, were included in two trials.17,18 In both, significant
improvements were shown in the treatment arm compared
with control. In one,17 numbers needed to treat were
identified as two at 1 month and four at 12 months.
Implications for physiotherapists
Clearly, breathing exercises for people with asthma have
demonstrable benefits on health-related quality of life. The
study by Bowler et al.17 showed an effect of Buteyko over
and above that of abdominal breathing, education and
relaxation; the study by Thomas et al.18 however, indicated
that physiotherapy treatment that focused on slowing the
breathing pattern achieved good results compared with
education alone. Where over-breathing is a component of
the manifestation of asthma symptoms, the focus should be
on exercises that maximize conscious control of nose
breathing, aim to decrease ventilation and ‘re-establish a
more normal and slower pattern of movement’.19Practice point
Breathing exercises, containing an element of hypo-
ventilation, in patients with asthma, result in signifi-
cant improvements in health-related quality of life.
Systematic review 2: bronchopulmonary
hygiene physical therapy for chronic
obstructive pulmonary disease and
bronchiectasis
Where respiratory patients have difficulty with impaired
airway clearance, physical therapists commonly apply
techniques to assist clearance of secretions. Although
short-term trials show evidence of benefit in cystic fibrosis,20
the data are controversial in conditions such as bronchiec-
tasis and chronic obstructive pulmonary disease (COPD). In
this systematic review, the effects of manual interventions,
such as postural drainage, chest percussion, vibration, chest
shaking, directed coughing, or forced exhalation technique,
were considered on the outcomes of lung function, pulmon-
ary clearance and symptoms.21 Ninety-nine potential studies
were identified, and a total of seven RCTs were included, of
which five concerned the evaluation of treatment compared
with no treatment. Unfortunately, interventions and patient
populations were different, meaning that trials could not be
combined statistically.
Pulmonary clearance
Two trials in bronchiectasis evaluated the effect of postural
drainage plus percussion22 and postural drainage plus forced
expiration techniques23 on sputum production and radio-
isotope clearance. In both studies, physiotherapy treatment
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group. In chronic bronchitis, postural drainage, cough and
exercise also improved airway clearance as measured by
radioisotope, whereas postural drainage in isolation was
ineffective.24
Pulmonary function and oxygenation
Studies investigating effects on pulmonary function and
oxygenation did not show benefit in either acute exacerba-
tions of COPD25 or in chronic COPD.26
Methodological limitations
Jones and Rowe21 acknowledge and highlight significant
methodological flaws in study designs, populations and
reporting. Few studies evaluated bronchopulmonary hygiene
techniques in patients with acute respiratory disease, and
those studies that did were of poor methodological quality
and did not clearly characterize patients.
In the case of Newton and Bevans25 79 patients with an
acute exacerbation of COPD were stratified into three
groups. The first two were men with PaO2o8 kPa, and men
with PaO2 above this. Women then made up a third group.
Randomization into control versus physiotherapy was
then carried out and data analysed for sub-groups only.
This meant that groups were small, with 27 in group 1, 13
in treatment arm and 14 in control arm; 36 in group 2 and
only 16 in the third group. No significant differences were
found as a result of treatment in these small groups,
with the exception of increased sputum production in the
last 3 days of hospitalization in men without hypoxaemia as
a result of physiotherapy. Results of all group analysis are
not shown.
Implications for physiotherapists
This summary clearly shows that bronchopulmonary hygiene
techniques in COPD and bronchiectasis increase sputum
production. Frequent exacerbation is associated with
increased sputum and high bacterial load.27 In addition, up
to half of patients with severe COPD have bronchiectasis on
high resolution chest computed tomography.28 Increased
bacterial load in sputum is associated with increased
frequency of exacerbation,29 and physiotherapy aids sputum
clearance.22 Although associations cannot inform us about
cause, there may be important therapeutic benefit of
improved sputum clearance. In the absence of studies
informing us of the long-term effects of bronchopulmonary
hygiene techniques on morbidity and mortality, physiothera-
pists would do well to continue treatment of sputum hyper-
secretion using the evidence-based approaches described
above.Practice point
Physiotherapy treatment enhances sputum production,
whether this is of long-term clinical benefit remains to
be seen.Research priorities
RCTs of bronchopulmonary hygiene techniques are
required that evaluate effects on health-related
quality of life, exacerbation frequency and hospital
admission. Investigation should include long-term
follow-up.
Systematic review 3: pulmonary rehabilitation
for chronic obstructive pulmonary disease
This recently updated review strongly supports the role of
pulmonary rehabilitation in the management of people with
COPD.30 Physical therapists are crucial to the delivery of
rehabilitation because of their training in exercise and
movement therapies. Trials were considered if an exercise
component (with or without education) was compared with
usual treatment or a non-exercise control group. An impress-
ive 31 RCTs met the inclusion criteria for this review, and
statistically significant improvements were seen for health-
related quality of life and functional exercise capacity.
Health-related quality of life
Weighted mean differences (WMD) were calculated from the
difference between pre- and post-intervention changes.
Thirteen of the studies had measured health-related quality
of life, although only the valid measures of St. George’s
Hospital Respiratory Questionnaire,31 The Chronic Respira-
tory Disease Questionnaire (CRQ)32 and the Transitional
Dyspnoea Index33 were considered. The reviewers compared
effect sizes with that of the minimal clinically important
difference (MCID) where these have previously been
determined. The MCID determines the smallest difference
in score that equates to a meaningful clinical change, and
have been calculated for the above outcome measures.
Using WMD, the effect size of pulmonary rehabilitation on
health-related quality of life was greater than the clinical
difference for all domains of the CRQ. Indeed, effects of
rehabilitation on the dyspnoea component of CRQ were
larger than the MCID of 0.5 units, implying an important
clinical benefit of therapy; WMD 1.0 units, 95% CI: 0.8–1.3
units. Data were similarly positive for St. George’s Hospital
Respiratory Questionnaire, and again the common effect
size exceeded the MCID of 4 points.
Maximal exercise tolerance
An important aim of pulmonary rehabilitation is to increase
exercise tolerance and functional ability for people limited
by their respiratory disease. As evidence shows a close
relationship between lower exercise tolerance and admis-
sion and readmission to hospital, this is a fundamental
clinical aim.34 Pooled data showed a statistically significant
effect of rehabilitation on maximal exercise tolerance using
cycle ergometry, mean difference (95% CI) 8.4W (3.4–13.4).
No MCID is available for maximal exercise assessed in this
way, although the difference is similar to the increase in
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patients with chronic atrial fibrillation, suggesting it may
have clinical relevance.35
Functional exercise tolerance
Using the six-minute walking distance (6MWD) as a measure
of functional exercise tolerance, mean improvement be-
tween control and active groups was 48m (95% CI 32–65).
This mean difference is close to the MCID of 6MWD identified
as around 50m, although the lower confidence interval
marginally falls below MCID confidence intervals of
37–71m.36 Clinical significance of the benefits of pulmonary
rehabilitation on functional exercise tolerance is therefore
not irrefutably proven; however, other evidence highlighting
improvement in daily activity performance with rehabilita-
tion does support clinical benefit.37,38
The principal reason for performing a meta-analysis is the
opportunity to increase the statistical power of individual
studies. In the case of this review, results from some
individual trials do not reach statistical significance, or are
too imprecise to allow useful inference. Data from one
community study, for instance, show a small mean differ-
ence of only 5m,39 and in another small study (consisting of
a brief hospital intervention with home follow-up), the
mean difference was 0m.40 In another small study, a large
effect size of rehabilitation was seen (143.6m); however,
the confidence intervals around the mean were large
(74.3–212.9), reflecting the very small sample size
(n ¼ 7).41 Pooling data from this and other similar studies
gave a sample size of 323 participants, and a WMD of 48.5m
with tighter confidence intervals 31.6–65.2m, reflecting the
larger sample size (Fig. 1).
Methodological limitations
Although the review authors conclude that studies compar-
ing rehabilitation with a waiting list or usual care group areFigure 1 Forest plot of maximal exercise capacity from the Co
represented by the horizontal lines in relation to the vertical line w
of each horizontal line reflects how precise the difference was for ea
by the black diamond at the bottom of the graph, with the numerica
to the right, with its associated 95% confidence intervals.no longer of importance, it must be remembered that RCTs
concerning effects on hospitalizations and exacerbation are
still lacking. Although able to provide evidence of effec-
tiveness on exercise tolerance and quality of life, this
review was not able to describe the relationship between
appropriate initiation of this intervention, disease severity
and hospitalization that has come to be emphasized in
clinical guidelines. Owing to the chronic, persistent nature
of COPD, a longer-term perspective of rehabilitation is
required, especially as the perception of health benefit and
depressive co-morbidities may influence adherence to
treatment.42
Implications for physiotherapists
Pulmonary rehabilitation is a well-proven effective therapy
that results in important health benefits for people with
COPD. Physiotherapists, trained as they are in the delivery
of rehabilitative and physical approaches, should remain at
the forefront of delivery of rehabilitation and maximize
opportunities for all people with COPD.Practice point
Pulmonary rehabilitation should be available to people
with COPD, with the aim of improving breathlessness,




Further research would be recommended to identify
long-term effects of rehabilitation and strategies to
ensure optimization of service delivery.ane review by Lacasse et al. The individual trial data are
h represents no statistically significant difference. The width
trial. The weighted average of these estimates is represented
lue of the widest point of the diamond (point estimate) given
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training for asthma
Generalized muscle weakness is common in patients with
respiratory disease, and is known to contribute to reduction
in exercise tolerance and dyspnoea. In people with asthma,
increased use of steroids, reduced exercise capacity and
inflammatory processes may contribute to respiratory
muscle weakness. Feasibly, weakness may be a contributory
factor towards the sensation of dyspnoea.43 Alternatively, it
has been argued that, in asthma, as work of breathing is
increased, inspiratory muscle strength is increased com-
pared with healthy people.44 Whether alterations in max-
imal inspiratory and expiratory pressures reflect true
weakness, or are rather a feature of dynamic hyperinflation
remains controversial. However, empirical evidence of
improvement in breathlessness in association with increase
in respiratory muscle strength would support the former
hypothesis. Devices are now available to assist the training
of respiratory muscles, and a number of studies have
examined the effect of respiratory muscle training in
asthma45 and COPD.46 Physical therapists are familiar with
the physiological principles of training and the application of
respiratory muscle training in people with respiratory
disease. In this systematic review, the role of inspiratory
muscle training (IMT) in asthma is considered.47
Only studies that compared the use of an external
resistive training device with sham treatment (or usual
care) were considered. Patients had stable asthma accord-
ing to recognized criteria. Five RCTs48–51 were included in
the review.
Effects of training on maximal inspiratory pressure
(cm H2O)
Four of the above studies were included in this analysis
comprising 94 participants. WMD showed a significant effect
of IMT on maximal inspiratory pressure compared with
control group (20.2 cm H2O; 95% CI 13.2–27.2). As the
studies were heterogeneous, a random-effects model was
applied. This did not alter the results, although WMD was
smaller and confidence intervals wider.
Effects of training on lung function
Two studies reported on FEV1 and forced vital capacity.
45,50
However, these outcomes were reported differently: as
percent predicted and absolute change. The combined
standardized mean difference was not significant for either
outcome. One study showed a significant increase in percent
forced vital capacity in the treatment group compared with
control group (mean difference 15.6%).45
Effect of peak expiratory flow rate
Only McConnell et al.50 reported on this; no significant
difference was found in peak expiratory flow rate after
training compared with controls.
A number of other outcomes were considered of
importance by the reviewer; asthma symptoms, inspiratorymuscle endurance, exacerbations, days off work or school
and oral corticosteroid usage. Of the five studies reviewed,
no data were available for effects of IMT on any of these
outcomes. It is of note that four of the included studies were
from the same research group.
Methodological limitations
The main outcome of this review is that IMT increases
maximal inspiratory pressure compared with control group
of no training or sham training only. However, the clinical
relevance of this remains difficult to interpret, owing to the
fact that measures of lung function show little change and
importantly there is neither assessment of symptoms nor
evaluation of long-term effects on health-related quality of
life or dyspnoea. There remain significant methodological
limitations of studies investigating IMT, including small
sample size, mixed populations, difficulties with accurately
describing intensity, duration and the frequency of training
applied. Furthermore, maximal inspiratory pressure is a
volitional test and therefore open to criticism.52 Several
different respiratory muscle training devices are available,
ranging from sophisticated computerized systems to simple
hand-held resistive devices. In addition, the relative
benefits of strength versus endurance training, inspiratory
versus expiratory training and effect in patients of differing
severity are unknown.
Implications for physiotherapists
Although the routine use of IMT cannot yet be recom-
mended, where the therapist considers that respiratory
muscle weakness is of primary importance in the manifesta-
tion of symptoms, a trial of respiratory muscle training may
be undertaken.Practice point
IMT improves maximal inspiratory strength; however,
the clinical relevance of this is at present unclear.Research priorities
 Long-term randomized, double-blinded, controlled
trials are required that evaluate the effect of I MT
on quality of life, dyspnoea and exacerbations in
people with asthma.
 The effect of IMT requires assessment using non-
volitional tests of respiratory muscle strength in
people with asthma.Conclusions
In this article, we provide an evidence-based overview of
four Cochrane reviews of relevance to physiotherapeutic
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treatments commonly used by physiotherapists: breathing
exercises; bronchopulmonary hygiene techniques; and phy-
sical training for peripheral and respiratory muscles. These
reviews reflect the varied nature of physiotherapy practice.
Physiotherapists aim to improve ventilation for people with
respiratory disease and, as shown above, they may approach
this using a variety of techniques. The reviews show that
breathing exercises can have beneficial effects on health-
related quality of life in asthma, that IMT improves
inspiratory muscle strength and that bronchopulmonary
techniques aid clearance of sputum. However, the clinical
relevance of these treatments and long-term effects on
morbidity are as yet unknown.
The unequivocal importance of pulmonary rehabilitation
in the management of COPD is once again reinforced. Recent
data from a cohort study demonstrate a protective effect of
physical activity on mortality and hospital admissions in
COPD.53 It is likely that the effects of pulmonary rehabilita-
tion will extend to other important outcomes, such as
hospital admission and re-admission.54
The process of pre-defining clinical questions, extensive
literature searches and critical appraisal that characterizes
Cochrane reviews has provided physiotherapists and other
clinicians with carefully assembled summaries of evidence
of the effects of interventions in the management of
respiratory disease. To varying degrees, these reviews serve
as the basis for informing the practice and provision of
physiotherapy services to patients with chronic respiratory
disease. They also highlight crucial areas of research that
require further exploration. Unfortunately, Cochrane re-
views rarely answer questions of equal importance, which is
that if we can show something works, what is it that
facilitates successful roll-out at service level? This is
particularly relevant for the delivery of pulmonary rehabi-
litation. Often these questions require an empirically
rigorous basis provided by systematic reviews, before we
can progress and ask other important questions. In time, the
findings of such qualitative studies should feed into the
evidence-gathering process. The observations that can be
made from cohort and other observational or qualitative
studies have the potential to provide guidance to the design
of intervention studies, making such studies, and the
reviews that assess them, of increasing relevance to the
daily practice of physiotherapy.
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